Nantes Castillejo, O.
29  Ergebnisse:
Personensuche X
?
1

OP37 Is the withdrawal of anti-tumour necrosis factor in in..:

Chaparro, M ; García Donday, M ; Riestra, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i50-i54 , 2023
 
?
2

P410 Which patients with established Crohn's disease benefi..:

Elosua Gonzalez, A ; Rullan Iriarte, M ; Rubio Iturria, S...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S417-S418 , 2021
 
?
3

P418 Does capsule endoscopy impact clinical management in e..:

Elosua Gonzalez, A ; Rullan Iriarte, M ; Rubio Iturria, S...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S423-S424 , 2021
 
?
4

P286 Rate of colectomy in ulcerative colitis: Results from ..:

Rodriguez Gutiérrez, C ; Elosua Gonzalez, A ; Prieto Martínez, C...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S295-S296 , 2020
 
?
5

P559 Real-life experience with long-term maintenance of gol..:

Iborra, M ; García-Morales, N ; Rubio, S...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S393-S394 , 2019
 
?
 
?
7

Primary mesothelial cyst of the spleen as an uncommon cause..:

Elosua González, A. ; Nantes Castillejo, O. ; Tarifa Castilla, A..
Revista de Gastroenterología de México (English Edition).  83 (2018)  4 - p. 463-465 , 2018
 
?
8

P425 Proactive measurement of infliximab trough levels vs. ..:

Elosua González, A ; Oyón Lara, D ; Sanz Segura, P...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S319-S320 , 2018
 
?
 
?
13

Síndrome colestásico secundario a hepatotoxicidad por labet..:

M. Vicuña Arregui ; D. Ruiz-Clavijo García ; J. M. Zozaya Urmeneta..
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082010000400014.  , 2010
 
?
 
?
15

Ustekinumab in Crohn's disease: Effectiveness and safety in..:

Saldaña Dueñas, Cristina ; Rullán Iriarte, María ; Elosua González, Alfonso...
Gastroenterología y Hepatología (English Edition).  43 (2020)  9 - p. 497-505 , 2020
 
1-15